Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Stereotactic Hypofractionated Accelerated Radiotherapy Post-Prostatectomy: a Phase I Feasibility Study

NCT02976402 is registered in ClinicalTrials.gov with Fundacao Champalimaud as lead sponsor.

NCT NCT02976402
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02976402 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Stereotactic Hypofractionated Accelerated Radiotherapy Post-Prostatectomy: a Phase I Feasibility Study
Lead sponsor
Fundacao Champalimaud
Phase
Phase 1
Overall status
Unknown status
Start date
November 30, 2016
Completion date
November 30, 2022
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adjuvant radiotherapy, igrt, prostate cancer adenocarcinoma, salvage radiotherapy, sbrt, urethral sparing